Design Therapeutics, Inc. DSGN Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
The Company manages the business activities at the consolidated level and operates in one operating and reportable segment. The Company’s CODM is its chief executive officer. The CODM primarily utilizes long-range financial projections and cash runway in order to allocate resources and to assess performance. As of March 31, 2026, the Company has no revenue and all the Company’s long-lived assets were located within the United States. The CODM is regularly provided with the following significant segment expenses:
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s total revenue?
- Design Therapeutics, Inc. (DSGN) reported total revenue of $0 in Q1 2026.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Design Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
